Skip to main
IQV
IQV logo

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 47%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings is experiencing robust growth across its segments, particularly in its FSP, RWE, and CSMS divisions, which demonstrated year-over-year improvements in Q3. The company has also observed a positive shift in the commercial side, marked by enhanced client decision timelines and a strong pipeline fueled by recent drug launches, as indicated by a low-teens year-over-year growth in RFP flow. Furthermore, IQVIA's win rate has markedly increased, and the pricing environment has improved, allowing the company to strategically walk away from less favorable deals, thereby positioning itself for a projected growth rate of over 4% in its R&D Services segment on a constant currency, ex-COVID basis.

Bears say

IQVIA Holdings has experienced a decline in year-over-year constant currency growth, with a significant drop from 6.8% in the second quarter of 2025 to 3.8% in the most recent report, highlighting challenges in maintaining growth momentum. The company's guidance indicates that it would be disappointed if 2026 revenue growth falls below 5%, which raises concerns about its ability to meet investor expectations amid worsening revenue growth trends. Additionally, operational challenges, such as low hiring rates and the impact of passthrough costs on margins, coupled with external pressures like rising interest rates, further contribute to a negative outlook for the company's financial performance.

IQVIA Hlds (IQV) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 47% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 17 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $243.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $243.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.